Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,625,588
  • Shares Outstanding, K 214,786
  • Annual Sales, $ 872,000 K
  • Annual Income, $ -23,550 K
  • 60-Month Beta 0.97
  • Price/Sales 3.90
  • Price/Cash Flow N/A
  • Price/Book 10.51
Trade HIMS with:

Options Overview Details

View History
  • Implied Volatility 72.38% ( +17.45%)
  • Historical Volatility 98.96%
  • IV Percentile 74%
  • IV Rank 41.93%
  • IV High 112.84% on 05/03/24
  • IV Low 43.17% on 09/14/23
  • Put/Call Vol Ratio 0.45
  • Today's Volume 124,123
  • Volume Avg (30-Day) 43,192
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 224,129
  • Open Int (30-Day) 177,352

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.05
  • Number of Estimates 7
  • High Estimate 0.05
  • Low Estimate 0.02
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +266.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.20 +70.54%
on 05/03/24
20.11 -5.02%
on 05/20/24
+6.60 (+52.80%)
since 04/26/24
3-Month
11.20 +70.54%
on 05/03/24
20.11 -5.02%
on 05/20/24
+5.77 (+43.29%)
since 02/28/24
52-Week
5.65 +238.05%
on 10/30/23
20.11 -5.02%
on 05/20/24
+10.03 (+110.58%)
since 05/26/23

Most Recent Stories

More News
A New Name in Weight Loss Drugs

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

HIMS : 19.10 (+13.15%)
NVO : 134.08 (-1.44%)
LLY : 807.86 (+0.05%)
XPOF : 9.50 (+4.40%)
WIX : 165.06 (-2.91%)
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?

Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.

NVO : 134.08 (-1.44%)
BMO : 96.11 (+0.67%)
CTLT : 54.00 (-1.50%)
HIMS : 19.10 (+13.15%)
LLY : 807.86 (+0.05%)
The Ultimate Growth Stock to Buy With $20 Right Now

I challenge you to name another $20 stock with more long-term potential.

HIMS : 19.10 (+13.15%)
Is Hims & Hers Stock a Buy for GLP-1 Upside?

Hims & Hers is a digital health company that is firing on all cylinders, while improving its profit margins at a robust pace.

HIMS : 19.10 (+13.15%)
LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
Hims & Hers Is Changing the Game

GLP-1s could be the product that pushes Hims & Hers over the edge to mainstream adoption.

HIMS : 19.10 (+13.15%)
Him & Hers Health Stock Soars After Cheap Weight-Loss Drug Offering

Him & Hers Health (NYSE:HIMS) is a San Francisco-based telehealth platform that connects consumers to ...

HIMS : 19.10 (+13.15%)
Stocks Settle Mixed on Hawkish Fed Comments

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.69%. US stock indexes...

$SPX : 5,306.04 (+0.02%)
SPY : 529.81 (+0.07%)
$DOWI : 38,852.86 (-0.55%)
DIA : 388.60 (-0.52%)
$IUXX : 18,869.44 (+0.32%)
QQQ : 459.68 (+0.38%)
ZNM24 : 108-040 (-0.16%)
NCLH : 16.56 (+3.50%)
CCL : 15.65 (+3.44%)
RCL : 150.13 (+1.15%)
JBL : 118.77 (-0.69%)
TER : 145.23 (+0.85%)
Stocks are Mixed in Afternoon Trade

The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.64%. US stock indexes today are mixed,...

$SPX : 5,306.04 (+0.02%)
SPY : 529.81 (+0.07%)
$DOWI : 38,852.86 (-0.55%)
DIA : 388.60 (-0.52%)
$IUXX : 18,869.44 (+0.32%)
QQQ : 459.68 (+0.38%)
ZNM24 : 108-040 (-0.16%)
NCLH : 16.56 (+3.50%)
CCL : 15.65 (+3.44%)
RCL : 150.13 (+1.15%)
TER : 145.23 (+0.85%)
MU : 132.67 (+2.46%)
Is Hims & Hers Health Stock a Buy?

A six-point argument that shares are a table-pounding opportunity worth scooping up now.

WMT : 65.04 (-0.52%)
HIMS : 19.10 (+13.15%)
Hims & Hers Health Shares Climb After News of Double-Digit Revenue Growth. Is It Too Late to Buy the Stock?

The stock is one of the cheapest high-growth stocks around.

HIMS : 19.10 (+13.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 21.66
2nd Resistance Point 20.41
1st Resistance Point 19.75
Last Price 19.10
1st Support Level 17.84
2nd Support Level 16.59
3rd Support Level 15.93

See More

52-Week High 20.11
Last Price 19.10
Fibonacci 61.8% 14.59
Fibonacci 50% 12.88
Fibonacci 38.2% 11.17
52-Week Low 5.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar